Remodeling Amyloid Fibers: Baker's Yeast Shows Us the Way

Eva Asp1, Ming Proschitsky1, Rajaraman Krishnan1

  • 1Neurophage Pharmaceuticals, 222 Third Street, Suite 3120, Cambridge, MA 02142, USA.

Chemistry & Biology
|August 22, 2015
PubMed

Insights

Researchers harnessed a yeast protein, Hsp104, to break down amyloid fibrils. This protein disaggregation method offers potential therapeutic strategies for proteopathies like Alzheimer's and Parkinson's disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Proteopathies are diseases caused by protein misfolding, including Alzheimer's and Parkinson's.
  • Amyloid fibril formation is a common characteristic of these debilitating neurodegenerative diseases.
  • Current treatments for proteopathies are limited, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

  • To investigate the potential of the yeast protein Hsp104 as a disaggregase for amyloid fibrils.
  • To explore a novel strategy for combating protein misfolding diseases.

Main Methods:

  • Utilizing Hsp104, a protein from baker's yeast, known for its protein disaggregation capabilities.
  • Applying Hsp104 to disaggregate pre-formed amyloid fibrils associated with proteopathies.

Main Results:

  • Demonstrated the efficacy of Hsp104 in breaking down amyloid fibrils.
  • Showcased the potential of protein disaggregation as a therapeutic avenue for proteopathies.

Conclusions:

  • Hsp104 can be harnessed to disaggregate disease-associated amyloid fibrils.
  • This study presents a promising new approach for developing treatments for proteopathies.